Group 1 - The core point of the article is that New Industry (SZ 300832) has recently received multiple invention patents from both the National Intellectual Property Administration of China and the Russian Federal Intellectual Property Office, indicating a strong focus on innovation in the biomedical sector [1] - The patents include "Detection Reagents, Kits, and Methods for Latex Immunoassay" and "Cleaning Module and Sample Analyzer with It," showcasing the company's advancements in diagnostic technology [1] - As of the latest report, New Industry has a market capitalization of 49.8 billion yuan, reflecting its significant position in the market [3] Group 2 - For the first half of 2025, New Industry's revenue composition shows that 99.84% comes from in vitro diagnostics, highlighting the company's strong focus on this segment [2] - Other business segments contribute only 0.16% to the total revenue, indicating a highly specialized operational focus [2]